|
Index of reports
> Cases with Depression (79)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include depression. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 79 Next >>
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient:
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 ?g, qw
Indication: Hepatitis C
Start date: 2012-04-27
Ribasphere
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-27
Other drugs received by patient: Prograf
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-24
Patient:
Reactions: Fatigue, Insomnia, Depression, Influenza Like Illness
Drug(s) suspected as cause:
PEG-Intron
Administration route: Oral
Ribasphere
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Other drugs received by patient: Prozac; Ambien
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-24
Patient:
Reactions: Depression
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-07-06
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-07-12
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-07-12
Other drugs received by patient: Gasmotin; Allegra; Nizatidine; Miltax PAP; Lexapro; Allopurinol; Mucosta; Urso 250; Allopurinol; Meilax; Loxonin; Rinderon V; Myser (Cycloserine); Zolpidem
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.5 ml, unk
Indication: Hepatitis C
Start date: 2012-04-13
PEG-Intron
Dosage: 0.4 ml, unk
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Fatigue, Alopecia, Vision Blurred, Depression, Rash, Tremor
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Abdominal Pain, Intervertebral Disc Protrusion, Pain, Anaemia, Rash, Fall, Diverticulum Intestinal, Osteoarthritis, Colonic Polyp, Spinal Fusion Surgery, Fatigue, Iron Deficiency Anaemia, Dyspepsia, Depression, Leukopenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-18
Ribasphere
Dosage: 600mg am and 400mg pm
Start date: 2012-01-18
Telaprevir
Dosage: unk
Start date: 2012-02-01
End date: 2012-01-01
Other drugs received by patient: Escitalopram Oxalate; Tizanidine Hydrochloride; Tylenol; Flector; Hydroxyzine Hydrochloride; Ibuprofen; Aleve; Flexeril; Omeprazole; Claritin
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Inappropriate Schedule of Drug Administration, Bunion, Confusional State, Pain in Extremity, Adrenal Neoplasm, Varicose Vein, Fatigue, Insomnia, NO Therapeutic Response, Depression, Nervousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2006-01-06
End date: 2006-06-23
PEG-Intron
Dosage: unk
Start date: 2012-07-06
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2006-01-06
End date: 2006-06-23
Rebetol
Dosage: unk
Administration route: Oral
Start date: 2012-07-06
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-22
Patient:
Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-22
PEG-Intron
Dosage: 1.0mcg/kg/week
Start date: 2012-02-29
End date: 2012-02-29
PEG-Intron
Dosage: 0mcg/kg
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-14
Rebetol
Administration route: Oral
Start date: 2012-02-15
End date: 2012-03-07
Rebetol
Administration route: Oral
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
End date: 2012-02-28
Telavic
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-07
Telavic
Administration route: Oral
Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22
Patient:
Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Blinded Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
PEG-Intron
Dosage: 120 micrograms, qw
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-06
Peginterferon Alfa-2B
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Placebo
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Rebetol
Dosage: 600 mg, bid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-02-11
End date: 2011-01-07
Ribavirin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Simvastatin
Dosage: 800 mg, tid
Administration route: Oral
Start date: 2010-03-11
End date: 2011-01-07
Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-14
Patient:
Reactions: White Blood Cell Count Decreased, Depression
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-16
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-13
End date: 2012-07-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-08
End date: 2012-07-12
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Telavic
Dosage: 2250 mg, qd
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-14
Patient:
Reactions: Malaise, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-29
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-07-04
Telavic
Administration route: Oral
Start date: 2012-05-29
End date: 2012-07-03
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-29
Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-13
Patient:
Reactions: Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.3mcg/kg
Start date: 2012-05-29
Rebetol
Administration route: Oral
Start date: 2012-05-29
Telavic
Administration route: Oral
Start date: 2012-05-29
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-13
Patient:
Reactions: Renal Disorder, Anaemia, Depression, Hyperuricaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-03-23
Rebetol
Administration route: Oral
Start date: 2012-02-29
End date: 2012-03-25
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
Rebetol
Administration route: Oral
Start date: 2012-02-22
End date: 2012-02-28
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
Telavic
Administration route: Oral
Start date: 2012-02-22
End date: 2012-03-25
Other drugs received by patient: Urso 250; Gasmotin; Aspirin; Dogmatyl; Zaditen; Gasmotin; BIO Three; Hyalein; Diovan; Urso 250; Plavix; Famotidine; Pegasys; Loxonin; Amlodipine Besylate; Fucidine CAP; Amlodipine Besylate; Bisoprolol Fumarate; Mirtazapine; Diovan; Aspirin; Plavix; Bisoprolol Fumarate; Famotidine; Exforge; Exforge; Adofeed; Medicon (Dextromethorphan Hydrobromide); Hirudoid
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-09
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-09
Telaprevir
Dosage: unk
Indication: Hepatitis C
Start date: 2012-03-09
Other drugs received by patient: Valium; Advil; Xanax; Ambien
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Anaemia, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-01-01
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Other drugs received by patient: Vitamins (Unspecified); Fluticasone Propionate; Fluticasone Propionate; Tramadol Hydrochloride; Pravastatin Sodium; Phenergan HCL; Hydrochlorothiazide; Simethicone; Synthroid; Alprazolam; Prozac; Aspirin; Bentyl; Mupirocin
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Confusional State, Hepatitis C, Pain, Aggression, Respiratory Tract Congestion, Biliary Drainage, Cholecystectomy, Memory Impairment, Depression, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
End date: 2002-12-06
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
End date: 2002-12-06
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Japan on 2012-08-07
Patient:
Reactions: Renal Impairment, Anaemia, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-03-05
End date: 2012-04-01
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-03-04
PEG-Intron
Dosage: 80 microgram per week
Start date: 2012-04-02
End date: 2012-06-18
PEG-Intron
Dosage: 1.5 microgram per week
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-02-27
PEG-Intron
Dosage: 50 microgram week
Start date: 2012-03-12
End date: 2012-03-26
Peginterferon Alfa-2B
Dosage: unk
Peginterferon Alfa-2B
Dosage: 50 microgram per kilogram, qw
Start date: 2012-03-12
End date: 2012-03-26
Peginterferon Alfa-2B
Dosage: 80 microgram per kilogram, qw
Start date: 2012-04-02
Peginterferon Alfa-2B
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-02-27
Rebetol
Dosage: 600 mg, once
Administration route: Oral
Start date: 2012-04-02
End date: 2012-05-13
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-27
End date: 2012-03-02
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-02-26
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-02
Rebetol
Dosage: 400 mg, once
Administration route: Oral
Start date: 2012-05-14
End date: 2012-06-25
Telavic
Dosage: 1500 mg, once
Administration route: Oral
Start date: 2012-03-05
End date: 2012-04-01
Telavic
Dosage: 2250 mg, once
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-10
End date: 2012-03-04
Other drugs received by patient: Loxonin; [therapy Unspecified]; Lendormin D; Rabeprazole Sodium; Hirudoid; Locoid; Lendormin; Lendormin; [therapy Unspecified]; Xyzal; Petrolatum; Myser (Cycloserine); Electrolytes (Unspecified) (+) Sodium Lactate
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Depression, Spinal Disorder, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-01-18
Ribasphere
Dosage: unk
Start date: 2012-01-18
Telaprevir
Dosage: unk
Start date: 2012-02-01
End date: 2012-01-01
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Ribavirin
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-10-25
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2011-11-23
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03
Patient:
Reactions: Fatigue, DRY Skin, Depression, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2012-05-01
Ribasphere
Other drugs received by patient: Lasix
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite
Adverse event resulted in: disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-07-16
Ribasphere
Dosage: unk
Start date: 2012-04-27
End date: 2012-07-16
Telaprevir
Dosage: unk
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient:
Reactions: Bunion, Inappropriate Schedule of Drug Administration, Confusional State, Pain in Extremity, Adrenal Neoplasm, Varicose Vein, Fatigue, NO Therapeutic Response, Insomnia, Depression, Nervousness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2006-01-06
End date: 2006-06-23
PEG-Intron
Dosage: unk
Start date: 2012-07-06
Rebetol
Dosage: unk
Administration route: Oral
Start date: 2012-07-06
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2006-01-06
End date: 2006-06-23
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-28
Patient:
Reactions: Agitation, Abdominal Pain, Chills, Blood Count Abnormal, Hyperhidrosis, Suicidal Ideation, Fatigue, Dyspepsia, Anger, Depression, Mood Swings, Dysphagia, Nausea, Irritability, Flank Pain, Influenza Like Illness
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-05-26
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-01-24
End date: 2012-05-26
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-05-26
Other drugs received by patient: Lexapro; Prozac
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient:
Reactions: Vomiting, Rash Generalised, Dyspnoea, Nausea, Anaemia, Headache, Generalised Oedema, Anxiety, Fatigue, Diarrhoea, Mood Swings, Depression, Blindness, Muscle Spasms, Decreased Appetite, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 microgram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Ribasphere
Dosage: unk
Start date: 2012-04-27
Telaprevir
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25
Patient:
Reactions: Weight Decreased, Rash Generalised, Nausea, Anaemia, Pain, Fatigue, Arthralgia, Alopecia, Vision Blurred, Depression, Temperature Intolerance
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 microgram, qw
Indication: Hepatitis C
Start date: 2012-03-01
Ribasphere
Victrelis
Administration route: Oral
Other drugs received by patient: Cyanocobalamin; Vitamin E; Pyridoxine HCL; Ascorbic Acid; Flaxseed
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient:
Reactions: White Blood Cell Count Decreased, Nausea, Anaemia, Rash, Headache, Irritability, Dysgeusia, Fatigue, Malaise, Depression, Depressed Mood
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-13
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-11
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-20
Patient:
Reactions: Homicide, Haematocrit Decreased, Depression
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19
Patient:
Reactions: Depression, Depressed Mood
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mg, qw
Indication: Hepatitis C
Start date: 2010-10-20
Rebetol
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-18
Patient:
Reactions: Depression
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Avastin
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-07-14
Patient:
Reactions: Depression, Decreased Interest
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Ribavirin
Page 1 Next >>
|
